Impact of comorbidity on disease characteristics, treatment intent and outcome in diffuse large B-cell lymphoma: a Swedish lymphoma register study
出版年份 2018 全文链接
标题
Impact of comorbidity on disease characteristics, treatment intent and outcome in diffuse large B-cell lymphoma: a Swedish lymphoma register study
作者
关键词
-
出版物
JOURNAL OF INTERNAL MEDICINE
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2018-10-28
DOI
10.1111/joim.12849
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Treatment strategies and outcomes in diffuse large B-cell lymphoma among 1011 patients aged 75 years or older: A Danish population-based cohort study
- (2018) Maja Bech Juul et al. EUROPEAN JOURNAL OF CANCER
- Clinical pharmacology of oncology agents in older adults: A comprehensive review of how chronologic and functional age can influence treatment-related effects
- (2018) Ginah Nightingale et al. Journal of Geriatric Oncology
- A Host‐Dependent Prognostic Model for Elderly Patients with Diffuse Large B‐Cell Lymphoma
- (2017) Katsuhiro Miura et al. ONCOLOGIST
- R-CVP regimen is active in frail elderly patients aged 80 or over with diffuse large B cell lymphoma
- (2016) Kamel Laribi et al. ANNALS OF HEMATOLOGY
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms
- (2016) S. H. Swerdlow et al. BLOOD
- Management strategies and outcomes for very elderly patients with diffuse large B-cell lymphoma
- (2016) Dai Chihara et al. CANCER
- Registers of the Swedish total population and their use in medical research
- (2016) Jonas F. Ludvigsson et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Long-term survival in young and middle-aged Hodgkin lymphoma patients in Sweden 1992-2009-trends in cure proportions by clinical characteristics
- (2015) Ingrid Glimelius et al. AMERICAN JOURNAL OF HEMATOLOGY
- Factors that influence treatment decision-making in elderly DLBCL patients: a case vignette study
- (2015) M. W. M. van der Poel et al. ANNALS OF HEMATOLOGY
- The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma – a Swedish population-based study
- (2015) Mohammad Mohammadi et al. BMC CANCER
- Results of a large retrospective analysis of the effect of intended dose intensity of R-CHOP on outcome in a cohort of consecutive, unselected elderly patients withde novodiffuse large B cell lymphoma
- (2015) Toby A. Eyre et al. BRITISH JOURNAL OF HAEMATOLOGY
- Reply to age-related differences in quality of life among patients with diffuse large B-cell lymphoma
- (2015) Jessica N. Williams et al. CANCER
- Disease characteristics, patterns of care, and survival in very elderly patients with diffuse large B-cell lymphoma
- (2015) Jessica N. Williams et al. CANCER
- Comparative effectiveness of anthracycline-containing chemotherapy in United States veterans age 80 and older with diffuse large B-cell lymphoma
- (2015) Kenneth R. Carson et al. Journal of Geriatric Oncology
- Diffuse large B-cell lymphoma in the elderly: Impact of prognosis, comorbidities, geriatric assessment, and supportive care on clinical practice. An International Society of Geriatric Oncology (SIOG) Expert Position Paper
- (2015) Vicki A. Morrison et al. Journal of Geriatric Oncology
- Impact of comorbidities on the treatment of non-Hodgkin’s lymphoma: a systematic review
- (2015) Catherine Terret et al. Expert Review of Hematology
- Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations†
- (2014) L. Decoster et al. ANNALS OF ONCOLOGY
- Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry
- (2014) F. Ellin et al. BLOOD
- Comorbidity is an independent prognostic factor in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP: a population-based cohort study
- (2014) Andre Wieringa et al. BRITISH JOURNAL OF HAEMATOLOGY
- Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma: a prospective multicenter evaluation in 173 patients by the Lymphoma Italian Foundation (FIL)
- (2014) Alessandra Tucci et al. LEUKEMIA & LYMPHOMA
- An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era
- (2013) Z. Zhou et al. BLOOD
- Flexible parametric modelling of cause-specific hazards to estimate cumulative incidence functions
- (2013) Sally R Hinchliffe et al. BMC Medical Research Methodology
- Comparison of outcomes among patients aged 80 and over and younger patients with diffuse large B-cell lymphoma: a population based study
- (2013) Cindy Varga et al. LEUKEMIA & LYMPHOMA
- The impact of age, Charlson comorbidity index, and performance status on treatment of elderly patients with diffuse large B cell lymphoma
- (2012) Tung-Liang Lin et al. ANNALS OF HEMATOLOGY
- Modulated Chemotherapy According to Modified Comprehensive Geriatric Assessment in 100 Consecutive Elderly Patients with Diffuse Large B-Cell Lymphoma
- (2012) M. Spina et al. ONCOLOGIST
- Two sides of the medallion: poor treatment tolerance but better survival by standard chemotherapy in elderly patients with advanced-stage diffuse large B-cell lymphoma
- (2011) S. A. M. van de Schans et al. ANNALS OF ONCOLOGY
- External review and validation of the Swedish national inpatient register
- (2011) Jonas F Ludvigsson et al. BMC PUBLIC HEALTH
- Charlson Comorbidity Index is an independent prognostic factor among elderly patients with diffuse large B-cell lymphoma
- (2011) Yujin Kobayashi et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial
- (2011) Frédéric Peyrade et al. LANCET ONCOLOGY
- Population based study of prognostic factors and treatment in adult Burkitt lymphoma: a Swedish Lymphoma Registry study
- (2011) Tove Wästerlid et al. LEUKEMIA & LYMPHOMA
- Diffuse large B-cell lymphoma in the elderly: diffusion of treatment with rituximab and survival advances with and without anthracyclines
- (2011) Brian K. Link et al. LEUKEMIA & LYMPHOMA
- Cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab versus epirubicin, cyclophosphamide, vinblastine, prednisone and rituximab for the initial treatment of elderly “fit” patients with diffuse large B-cell lymphoma: results from the ANZINTER3 trial of the Intergruppo Italiano Linfomi
- (2011) Francesco Merli et al. LEUKEMIA & LYMPHOMA
- Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma
- (2010) Antonino Musolino et al. CANCER
- Unexplained differences between hospital and mortality data indicated mistakes in death certification: an investigation of 1,094 deaths in Sweden during 1995
- (2009) Lars Age Johansson et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- The 2008 WHO classification of lymphomas: implications for clinical practice and translational research
- (2009) E. S. Jaffe Hematology-American Society of Hematology Education Program
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started